J.L. Bainbridge & Co’s Thermo Fisher Scientific TMO Stock Holding History

J.L. Bainbridge & Co’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-323	Closed	-$216K	–	97
2021 Q4	$216K	Buy	+323	New	+$202K	0.02%	84
2021 Q3	–	Sell	-443	Closed	-$223K	–	97
2021 Q2	$223K	Hold	443	–	–	0.03%	85
2021 Q1	$202K	Buy	+443	New	+$211K	0.03%	85

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

J.L. Bainbridge & Co's TMO Position: Q1 2022 in Review

J.L. Bainbridge & Co sold out of Thermo Fisher Scientific (TMO) in Q1 2022, closing a stake of 323 shares — an estimated $216K sold.

J.L. Bainbridge & Co first reported a position in TMO in Q1 2021 and held it in 3 quarters. The position peaked at $223K in Q2 2021. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

J.L. Bainbridge & Co reported no remaining Thermo Fisher Scientific position as of Q1 2022 after selling out during the quarter.
J.L. Bainbridge & Co sold 323 Thermo Fisher Scientific shares in Q1 2022, an estimated $216K.
J.L. Bainbridge & Co first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 3 quarters.
J.L. Bainbridge & Co's Thermo Fisher Scientific position peaked at $223K in Q2 2021.
2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on J.L. Bainbridge & Co's 13F filing for Q1 2022, filed 6 May 2022.